This article is included in these additional categories:

Biological Weapons | Medical | R&D - Contracted | Small Business | USA | WMD Defenses

$6M for Intercellular Bio-agent Countermeasures

For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
Genetic Chemistry, Inc. in Palo Alto, CA received a $6 million cost-plus-fixed-fee contract for “research to develop countermeasures to an intercellular bio threat agent.” Work will be performed in Palo Alto, CA and is expected to be complete by July 28/11. Multiple bids were solicited in October 2006, and 1 bid was received by the Research, Development & Engineering Command Acquisition Center in Research Triangle Park, NC (W911NF-08-C-0023).

One Source: Hundreds of programs; Thousands of links, photos, and analyses

DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.


  • Save time
  • Eliminate your blind spots
  • Get the big picture, quickly
  • Keep up with the important facts
  • Stay on top of your projects or your competitors


  • Coverage of procurement and doctrine issues
  • Timeline of past and future program events
  • Comprehensive links to other useful resources